Literature DB >> 23611033

WHO revised definitions and reporting framework for tuberculosis.

.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23611033

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


× No keyword cloud information.
  24 in total

Review 1.  Medical management of drug-sensitive active thoracic tuberculosis: the work-up, radiographic findings and treatment.

Authors:  Jared Eddy; Taimur Khan; Frank Schembri
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study.

Authors:  Sabine Bélard; Jonathan Remppis; Sanne Bootsma; Saskia Janssen; Davy U Kombila; Justin O Beyeme; Elie G Rossatanga; Cosme Kokou; Kara K Osbak; Régis M Obiang Mba; Harry M Kaba; Afsatou N Traoré; Jonas Ehrhardt; Emmanuel B Bache; Arnaud Flamen; Sabine Rüsch-Gerdes; Matthias Frank; Ayôla A Adegnika; Bertrand Lell; Stefan Niemann; Peter G Kremsner; Marguerite M Loembé; Abraham S Alabi; Martin P Grobusch
Journal:  Am J Trop Med Hyg       Date:  2016-06-27       Impact factor: 2.345

3.  Scapular bone destruction: do not forget to think of tuberculosis in endemic areas.

Authors:  Barun Kumar Sharma; Varun Kumar Singh; Kumar Nishant; Deepak Das
Journal:  BMJ Case Rep       Date:  2013-07-04

4.  Drug-susceptible tuberculosis treatment outcomes and its associated factors among inmates in prison settings in Bauchi State, Nigeria, 2014-2018.

Authors:  Peter Okpeh Amede; Elizabeth Adedire; Aishat Usman; Celestine Attah Ameh; Faruk Saleh Umar; Chukwuma David Umeokonkwo; Muhammad Shakir Balogun
Journal:  PLoS One       Date:  2022-07-05       Impact factor: 3.752

5.  Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant Tuberculosis.

Authors:  Jung-Yien Chien; Shun-Tien Chien; Wei-Yih Chiu; Chong-Jen Yu; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Evaluation of community-based treatment for drug-resistant tuberculosis in Bangladesh.

Authors:  Joseph S Cavanaugh; Ekaterina Kurbatova; Negar N Alami; Joan Mangan; Zinia Sultana; Shahriar Ahmed; Vikarunessa Begum; Sabera Sultana; Paul Daru; Julia Ershova; Alexander Golubkov; Sayera Banu; James D Heffelfinger
Journal:  Trop Med Int Health       Date:  2015-11-17       Impact factor: 2.622

7.  High utility of contact investigation for latent and active tuberculosis case detection among the contacts: a retrospective cohort study in Tbilisi, Georgia, 2010-2011.

Authors:  Tsira Chakhaia; Matthew J Magee; Russell R Kempker; Medea Gegia; Leila Goginashvili; Ucha Nanava; Henry M Blumberg
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

8.  Comparison of clinical manifestations and treatment outcome according to age groups in adult patients with miliary tuberculosis.

Authors:  Jaehee Lee; Jae Kwang Lim; Eun Jin Kim; Deok Heon Lee; Yu Kyung Kim; Seung Soo Yoo; Shin Yup Lee; Seung Ick Cha; Jae Yong Park; Chang Ho Kim
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

9.  Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.

Authors:  Taye T Balcha; Erik Sturegård; Niclas Winqvist; Sten Skogmar; Anton Reepalu; Zelalem Habtamu Jemal; Gudeta Tibesso; Thomas Schön; Per Björkman
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.

Authors:  Chawangwa Modongo; Rafal S Sobota; Boikobo Kesenogile; Ronald Ncube; Giorgio Sirugo; Scott M Williams; Nicola M Zetola
Journal:  BMC Infect Dis       Date:  2014-10-09       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.